We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Feature

Actavis At 5: Where Pay-For-Delay Litigation Stands

Law360 (August 6, 2018, 6:47 PM EDT) -- It’s been a little over five years since the U.S. Supreme Court issued its landmark Actavis decision that found payments made by brand-name drugmakers to generics makers in patent settlements can...
To view the full article, register now.